Αρχική World News News digest – targeted ‘lava lamp’ treatment, skin cancer biopsies and the...

News digest – targeted ‘lava lamp’ treatment, skin cancer biopsies and the iKnife

Credit: John Marshall, Tumour Biology Lab & EM Unit

With news about the coronavirus pandemic developing daily, we want to make sure everyone affected by cancer gets the information they need during this time. 

We’re pulling together the latest government and NHS health updates from across the UK in a separate blog post, which we’re updating regularly. 

‘Lavalamp’ effect could make cancer drugs more powerful

A new study published in Science has revealed how drug molecules are organised when they enter a cell, and how this information could be used to make certain drugs hit their targets more effectively. Research found that cancer drug compounds become concentrated in certain spots within cells – like blobs in a lava lamp. Whilst scientists hope that a better understanding of this phenomenon could lead to more targeted cancer treatments, others think that other mechanisms should be explored. Find out more at Nature 

Swansea skin cancer patients receive pioneering procedure

Skin cancer patients in Swansea have become first in the world to receive complex biopsies while awake. Sentinel lymph node biopsies allow doctors to detect whether melanoma has spread in skin cancer patients, but the procedure was suspended due to Covid-19 restrictions on general anaesthetic. A team of plastic surgeons and anaesthetists at Sancta Maria Hospital are now the first to carry out the procedure without anaesthetic. So far nine patients have had the test. More on this at BBC.

Scientist uncover new mechanism driving colorectal cancer

MedicalXpress reports on a collaborative study that has revealed a new mechanism causing colorectal cancer. Research by VIB-UGent Center for Inflammation Research and Ghent University found that abnormal expression of the protein Zeb2 could allow harmful bacteria into the intestinal wall, causing inflammation and driving cancer progression. Scientists have now demonstrated how manipulating the immune system could prevent this development and potentially lead to new cancer treatments.  

Searching for novel connections in cancer metabolism

Dr George Poulogiannis is one of our scientists investigating the relationship between cellular metabolism, cancer and diet. In our blog post, we spoke to him about how his team have been investigating connections in metabolism by utilising a unique tool known as the iKnife, used in cancer surgery, in order to open the door to a better understanding of individual cancers. Whilst the team have uncovered new features of breast cancer biology linked to metabolism and diet, and have shown that a dietary fat restriction plays a major role in therapy response, some headlines were quick to jump to a ‘potential cancer cure.  

And finally 

A technique known as a liquid biopsy is allowing doctors to find out more about a patient’s cancer without the need for surgery. The technique analyses a patient’s blood, monitoring the DNA tumours release into the blood stream. By analysing the individual genetic makeup of a tumour, liquid biopsies can focus on a specific set of mutations and use them as a starting point to monitor the progression of cancer. Find the full story on our blog. 

Scarlett Sangster is a writer for PA Media Group

More on this topic

Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...

Καρκίνος: Ευεργετική για τους καρκινοπαθείς η άσκηση

Σημαντικά ωφέλη προσφέρει η άσκηση, ακόμη και σε ασθενείς με καρκίνο. Οι περισσότεροι ασθενείς αγνοούν τα οφέλη που μπορεί να έχει γι’ αυτούς η συχνή...

Prostate Cancer

The article is provided by Scientific Communications Officer of NIPD Genetics, Ms Marina Charitou (MSc) Prostate Cancer Awareness Prostate cancer is the second most common cancer...
- Advertisment -

Ροή Ειδήσεων

An existing blood test for ovarian cancer has been re-evaluated. The results are in.

Ovarian cancer is the sixth most common cancer in women in the UK, with about 7,400 new cases every year. This number equates to...

How to Stay Healthy After Cancer

I try to pack helpful advice into every follow-up visit I have with patients, focusing on little tips that help foster healthy lifestyles. This...

Feasibility and Preliminary Efficacy Results of the Beat AML Study

Precision medicine in acute myeloid leukaemia (AML) is feasible in terms of providing cytogenetic and mutational data within 7 days, allowing their rapid incorporation into...

Woman Battles Breast Cancer While Pregnant, Delivers Healthy Baby Boy

When she was six months pregnant, Desiree Doughty noticed that something seemed to be wrong with her breasts. “I noticed that one of my breasts...

Pumpkin Season!

Halloween may look different this year but we can still decorate our homes and enjoy a favorite fall treat – pumpkin and pumpkin seeds....

ACHIEVE-2 Results of Oxaliplatin-Based Adjuvant Chemotherapy in Asian Patients with High-Risk Stage II Colon Cancer

The Asian researchers reported on 25 October 2020 in the Annals of Oncology that 3-month of combination therapy for adjuvant treatment of high-risk stage...